Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease (2021)
Fonte: Scientific reports. Unidade: FM
Assuntos: OLIGONUCLEOTÍDEOS, RIM, RETRATAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIDBERG, Kevin A et al. Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease. Scientific reports, v. 11, p. 1-20 , 2021Tradução . . Disponível em: https://doi.org/10.1038/s41598-021-84194-w. Acesso em: 21 ago. 2024.APA
Lidberg, K. A., Annalora, A. J., Jozic, M., Elson, D. J., Wang, L., Bammler, T. K., et al. (2021). Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease. Scientific reports, 11, 1-20 . doi:10.1038/s41598-021-84194-wNLM
Lidberg KA, Annalora AJ, Jozic M, Elson DJ, Wang L, Bammler TK, Ramm S, Caillaud MBCM, Himmelfarb J, Marcus CB. Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease [Internet]. Scientific reports. 2021 ; 11 1-20 .[citado 2024 ago. 21 ] Available from: https://doi.org/10.1038/s41598-021-84194-wVancouver
Lidberg KA, Annalora AJ, Jozic M, Elson DJ, Wang L, Bammler TK, Ramm S, Caillaud MBCM, Himmelfarb J, Marcus CB. Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease [Internet]. Scientific reports. 2021 ; 11 1-20 .[citado 2024 ago. 21 ] Available from: https://doi.org/10.1038/s41598-021-84194-w
